PATENT CLAIM ANALYSIS

Application Number: 15987550
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["546", "135000"]

Abstract:
A pyridone derivative compound and a pharmaceutically acceptable salt, isomer, solvate or hydrate thereof, and a preventive or therapeutic pharmaceutical composition for cognitive disorders that includes the pyridone derivative compound or a pharmaceutically acceptable salt, isomer, solvate or hydrate thereof.

Claim (Index 8):
A method for treating a disease mediated by an agonist or partial agonist of \u03b1 7-nicotinic acetylcholine receptor (nAChR) in a patient, comprising:\n administering to the patient a therapeutically effective amount of a compound of Formula I: \n or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein A is C 1 -C 10  heteroaryl optionally substituted by at least one selected from the group consisting of halo, chlorophenyl, C 1 -C 6  alkyl, C 3 -C 7  cycloalkyl, C 6 -C 12  aralkyl, C 1 -C 6  alkoxy, and C 6 -C 12  aryl; and B is O or NH.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 93.0
- Lexical Diversity: 1.76923
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14997754', '14581482', '13980821', '13980819', '13512464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7884311627606546
- 35 USC 102 Novelty (BERT): 0.5881733360305685
- Combined Prediction Score: 0.768405380087646
- Mean Citation Score: 436.347688
- Max Citation Score: 491.7693
- Similarity Product: 454.7914917840957

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test